|
|
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.
The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.
It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.
Company Strengths
Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters.
| Particulars | For the year/period ended (Rs in million) | |||
|---|---|---|---|---|
| 30-June-20 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | |
| Total Assets | 46,912.65 | 40,860.39 | 35,235.49 | 29,294.68 |
| Total Revenue | 9,162.89 | 27,724.08 | 21,297.67 | 16,716.82 |
| Profit After Tax | 3,135.90 | 7,728.58 | 4,518.56 | 3,210.51 |
The net proceeds from the IPO will be used for the following purposes:
| IPO Opening Date | Nov 9, 2020 |
| IPO Closing Date | Nov 11, 2020 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹1 per equity share |
| IPO Price | ₹1490 to ₹1500 per equity share |
| Market Lot | 10 Shares |
| Min Order Quantity | 10 Shares |
| Listing At | BSE, NSE |
| Issue Size | 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) |
| Fresh Issue | 8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) |
| Offer for Sale | 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr) |
The Gland Pharma IPO open date is Nov 9, 2020, and the close date is Nov 11, 2020. The issue may list on Nov 20, 2020.
| IPO Open Date | Nov 9, 2020 |
| IPO Close Date | Nov 11, 2020 |
| Basis of Allotment Date | Nov 17, 2020 |
| Initiation of Refunds | Nov 18, 2020 |
| Credit of Shares to Demat Account | Nov 19, 2020 |
| IPO Listing Date | Nov 20, 2020 |
The Gland Pharma IPO market lot size is 10 shares. A retail-individual investor can apply for up to 13 lots (130 shares or ₹195,000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 10 | ₹15,000 |
| Maximum | 13 | 130 | ₹195,000 |
| Pre Issue Share Holding | 74% |
| Post Issue Share Holding | 58% |
Related Articles
The Gland Pharma IPO is subscribed 2.06 times on 11/11/2020 6:00:01 PM. The public issue subscribed 0.24 in the retail category, 6.40 in the QIB category, and 0.51 in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 6.40 |
| NII | 0.51 |
| Retail | 0.24 |
| Total | 2.06 |
| Listing Date | Friday, November 20, 2020 |
| BSE Script Code | 543245 |
| NSE Symbol | GLAND |
| Listing In | B Group of Securities |
| ISIN | INE068V01023 |
| IPO Price | ₹1500 per equity share |
| Face Value | ₹1 per equity share |
|
|
|
Gland Pharma Limited
Sy. No. 143 - 148, 150 and 151,
Near Gandi Maisamma 'X' Roads, D.P. Pally,Dundigal
Medchal-Malkajgiri District, Hyderabad
Phone: +91 40 3051 0999
Email: investors@glandpharma.com
Website: http://www.glandpharma.com
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: glandpharma.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Gland Pharma IPO is a main-board IPO of 43,196,968 equity shares of the face value of ₹1 aggregating up to ₹6,479.55 Crores. The issue is priced at ₹1490 to ₹1500 per equity share. The minimum order quantity is 10 Shares.
The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Gland Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Gland Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Gland Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Gland Pharma IPO opens on Nov 9, 2020 and closes on Nov 11, 2020.
Gland Pharma IPO lot size is 10 Shares and the minimum order quantity is 10 Shares.
You can apply in Gland Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Gland Pharma IPO will be done on Nov 17, 2020, and the allotted shares will be credited to your demat account by Nov 19, 2020. Check the Gland Pharma IPO allotment status.
Ashish Khater
Useful Articles
IPO Mentor (600+ Posts, 500+ Likes)
Top Contributor (300+ Posts, 700+ Likes)
IPO Guru (1000+ Posts, 1700+ Likes)
